应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ILMN Illumina
休市中 11-15 16:00:00 EST
135.05
-7.19
-5.05%
盘后
135.08
+0.03
+0.02%
19:48 EST
最高
140.35
最低
133.42
成交量
474.18万
今开
140.35
昨收
142.24
日振幅
4.87%
总市值
214.19亿
流通市值
213.50亿
总股本
1.59亿
成交额
6.43亿
换手率
3.00%
流通股本
1.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
因美纳盘中异动 早盘股价大跌5.01%
市场透视 · 11-15 23:21
因美纳盘中异动 早盘股价大跌5.01%
因美纳2024财年第三财季实现净利润7.05亿美元,同比增加193.50%
市场透视 · 11-10
因美纳2024财年第三财季实现净利润7.05亿美元,同比增加193.50%
贝瑞基因与因美纳深化合作
每日经济新闻 · 11-07
贝瑞基因与因美纳深化合作
美国研究综述-信诺、万豪、拉尔夫-劳伦
Reuters · 11-05
美国研究综述-信诺、万豪、拉尔夫-劳伦
美国研究综述-信诺、万豪、拉尔夫-劳伦
Reuters · 11-05
美国研究综述-信诺、万豪、拉尔夫-劳伦
异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%
异动解读 · 11-05
异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%
异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%
异动解读 · 11-05
异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%
Illumina第四季度收入指引令人失望,股价盘后下跌2%
老虎资讯综合 · 11-05
Illumina第四季度收入指引令人失望,股价盘后下跌2%
因美纳将于美国人类遗传学会(ASHG)年会预展NGS及多组学技术前沿创新成果
美通社 · 11-01
因美纳将于美国人类遗传学会(ASHG)年会预展NGS及多组学技术前沿创新成果
美国研究综述-全州保险公司、布林克国际公司、梅塔公司
Reuters · 10-31
美国研究综述-全州保险公司、布林克国际公司、梅塔公司
Corvex 创始人迈斯特认为已被其他公司盯上的股票有很大的上升空间
Reuters · 10-23
Corvex 创始人迈斯特认为已被其他公司盯上的股票有很大的上升空间
美国研究综述-星座能源、摩根士丹利、优步
Reuters · 10-17
美国研究综述-星座能源、摩根士丹利、优步
BUZZ-伯恩斯坦预计美国生命科学企业第三季度业绩 "不可怕
Reuters · 10-16
BUZZ-伯恩斯坦预计美国生命科学企业第三季度业绩 "不可怕
因美纳推出迄今为止产品系列中最简便、最快速的桌面式测序仪----MiSeq i100系列
美通社 · 10-10
因美纳推出迄今为止产品系列中最简便、最快速的桌面式测序仪----MiSeq i100系列
Illumina 推出结构紧凑、成本低廉的基因测序设备
Reuters · 10-10
Illumina 推出结构紧凑、成本低廉的基因测序设备
异动解读 | 伊鲁米纳公司股价暴涨5.82%
异动解读 · 10-02
异动解读 | 伊鲁米纳公司股价暴涨5.82%
因美纳盘中异动 股价大涨5.13%报135.60美元
市场透视 · 10-02
因美纳盘中异动 股价大涨5.13%报135.60美元
BUZZ-在加拿大皇家银行将 PT 上调至街市高位后,Illumina 公司股价上涨
Reuters · 09-13
BUZZ-在加拿大皇家银行将 PT 上调至街市高位后,Illumina 公司股价上涨
监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权
智通财经 · 09-03
监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权
更新版 1-Illumina赢得 "圣杯 "之战,打击欧盟兼并势力
Reuters · 09-03
更新版 1-Illumina赢得 "圣杯 "之战,打击欧盟兼并势力
暂无数据
公司概况
公司名称:
Illumina
所属市场:
NASDAQ
上市日期:
--
主营业务:
Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成,2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务,包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。
发行价格:
--
{"stockData":{"symbol":"ILMN","market":"US","secType":"STK","nameCN":"Illumina","latestPrice":135.05,"timestamp":1731704400000,"preClose":142.24,"halted":0,"volume":4741753,"hourTrading":{"tag":"盘后","latestPrice":135.08,"preClose":135.05,"latestTime":"19:48 EST","volume":34967,"amount":4721973.4797,"timestamp":1731718118137},"delay":0,"floatShares":158092781,"shares":158600000,"eps":-9.984251,"marketStatus":"休市中","marketStatusCode":7,"change":-7.19,"latestTime":"11-15 16:00:00 EST","open":140.35,"high":140.35,"low":133.42,"amount":643287929.20874,"amplitude":0.04872,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.984251,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":964756800000,"adjPreClose":142.24,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":140.35,"preClose":142.24,"latestTime":"09:29 EST","volume":16895,"amount":2372186.4020000002,"timestamp":1731680999996},"postHourTrading":{"tag":"盘后","latestPrice":135.08,"preClose":135.05,"latestTime":"19:48 EST","volume":34967,"amount":4721973.4797,"timestamp":1731718118137},"volumeRatio":2.3970474851532586,"impliedVol":0.3917,"impliedVolPercentile":0.0913},"requestUrl":"/m/hq/s/ILMN/tweets","defaultTab":"tweets","newsList":[{"id":"2483303077","title":"因美纳盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483303077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483303077?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:21","pubTimestamp":1731684085,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时21分,因美纳股票出现波动,股价快速下挫5.01%。截至发稿,该股报135.11美元/股,成交量88.9043万股,换手率0.56%,振幅3.68%。因美纳股票所在的生命科学行业中,整体跌幅为2.34%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523212698e42fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523212698e42fac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4588","BK4585","BK4535","BK4548","ILMN","BK4534"],"gpt_icon":0},{"id":"2482427940","title":"因美纳2024财年第三财季实现净利润7.05亿美元,同比增加193.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482427940?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168208,"startTime":"0","endTime":"0","summary":"11月10日,因美纳公布财报,公告显示公司2024财年第三财季净利润为7.05亿美元,同比增加193.50%;其中营业收入为10.80亿美元,同比减少3.49%,每股基本收益为4.43美元。机构评级:截至2024年11月10日,当前有22家机构对因美纳目标价做出预测,其中目标均价为163.73美元,其中最低目标价为120.00美元,最高目标价为254.00美元。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000418a2278751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000418a2278751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ILMN"],"gpt_icon":0},{"id":"2481948018","title":"贝瑞基因与因美纳深化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2481948018","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481948018?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:37","pubTimestamp":1730957834,"startTime":"0","endTime":"0","summary":"每经AI快讯,11月6日,在第七届中国国际进口博览会上,贝瑞基因与全球基因测序仪巨头因美纳(Illumina)进行签约,这是双方深化合作、共同探索新技术领域的又一里程碑。此次合作是关于因美纳旗舰型高通量测序仪NovaSeq X Plus项目。NovaSeq X Plus 可实现每年超过20,000 个人标准基因组的测序,将单个人全基因组测序成本降至200美元,同时进一步提升了测序速度、规模、准确性和可持续性,能够支持更大规模、更高深度的测序、兼容更多种类的研究(从全基因组到多组学),推动基因测序技术的加速普及。每日经济新闻","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107133917a21f1813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107133917a21f1813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4548","BK4534","BK4588","BK4121","BK4585","ILMN"],"gpt_icon":0},{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":" 路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Cigna、万豪和 Ralph Lauren。要闻 * Cigna :Piper Sandler将目标价从392美元上调至394美元 * 万豪 :杰富瑞将目标价从 225 美元上调至 251 美元 * Ralph Lauren Corp :TD Cowen 将目标价从 208 美元上调至 251 美元 * Vertex Pharmaceuticals Inc :丰业银行将目标价从480美元上调至486美元 * Wynn Resorts Ltd :摩根大通将目标价从101美元上调至113美元 以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","GKOS","IRON","SM","KROS","LU0266512127.USD","LU1363072403.SGD","ST","CI","NMRA","OMI","EDIT","LU0320765489.SGD","EVER","LU","SHAK","MAR","ATUS","RL","LU0949170772.SGD","IE00BZ1G4Q59.USD","MDGL","BK4106","EGHT","BEN","ILMN","PTGX","LU0149725797.USD","LU1244550221.USD","NYT","HIMS","BMRN","AWI","SLAB","AMG","FRPT","CMS","CAMP","BWIN","INSP","RZLT","FIS","FOXA","LSCC","LU1489326972.SGD","ARES","LU0971096721.USD"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":" 路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Cigna、万豪和 Ralph Lauren。要闻 * Cigna :Piper Sandler将目标价从392美元上调至394美元 * 万豪 :杰富瑞将目标价从 225 美元上调至 251 美元 * Ralph Lauren Corp :TD Cowen 将目标价从 208 美元上调至 251 美元 * Vertex Pharmaceuticals Inc :丰业银行将目标价从480美元上调至486美元 * Wynn Resorts Ltd :摩根大通将目标价从101美元上调至113美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CI","EVER","BK4106","LU0320765489.SGD","CSTL","RZLT","SHAK","FOXA","ST","CMS","GKOS","LU1489326972.SGD","SLAB","NYT","PTGX","LU0266512127.USD","AWI","EDIT","KROS","LU0971096721.USD","LSCC","MAR","BWIN","IRON","ATUS","AMG","RL","LU0149725797.USD","LU0949170772.SGD","ARES","NMRA","FRPT","ILMN","IE00BZ1G4Q59.USD","INSP","OMI","LU1244550221.USD","BEN","MDGL","SM","BMRN","EGHT","FIS","LU","LU1363072403.SGD","CAMP"],"gpt_icon":1},{"id":"1150159083","title":"异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150159083","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150159083?lang=zh_cn&edition=full","pubTime":"2024-11-05 13:48","pubTimestamp":1730785711,"startTime":"0","endTime":"0","summary":"基因测序公司Illumina周四盘后大跌近6%,引发市场关注。主要原因是公司当天下调了2024年收入指引,预计2024年核心Illumina收入与2023财年相比将下降约3%,低于之前的乐观展望。公司将此归咎于近期宏观经济环境受限。投资者对上述指引不佳反应消极,纷纷抛售Illumina股票,导致盘后交易中股价大跌5.73%,报338.7美元。不过Illumina还有一些积极信号,包括第三季度业绩超预期,以及上调了2024年全年调整后每股收益指引至4.05-4.15美元区间,高于之前3.91美元预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"gpt_icon":0},{"id":"1151432613","title":"异动解读 | Illumina下调2024年收入指引 股价盘后大跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151432613","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151432613?lang=zh_cn&edition=full","pubTime":"2024-11-05 07:10","pubTimestamp":1730761833,"startTime":"0","endTime":"0","summary":"Illumina(ILMN)周四盘后大跌近6%,引发市场关注。盘后交易中,该股下跌5.73%,报338.7美元。\n\n造成Illumina股价大跌的主要原因是公司下调了2024年收入指引。Illumina预计2024年核心Illumina收入与2023财年相比将下降约3%,此前的展望较为乐观。公司将下调展望的原因归咎于近期宏观经济环境受限。\n\n同时,Illumina也下调了第四季度收入指引。公司预计第四季度收入约为10.7亿美元,低于分析师预测的11.5亿美元。尽管如此,Illumina上调了2024年全年调整后每股收益指引至4.05-4.15美元区间,高于之前的3.91美元预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"gpt_icon":0},{"id":"1117508454","title":"Illumina第四季度收入指引令人失望,股价盘后下跌2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117508454","media":"老虎资讯综合","labels":["Business Data","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117508454?lang=zh_cn&edition=full","pubTime":"2024-11-05 07:08","pubTimestamp":1730761715,"startTime":"0","endTime":"0","summary":"$Illumina$ 公布的第三季度盈利超过分析师预期,但由于公司第四季度收入指引低于预期,盘后交易中股价下跌2%。然而,Illumina对第四季度的展望令投资者失望。对于2024全年,Illumina下调了收入指引,现预计核心Illumina收入与2023财年相比将下降约3%。首席执行官Jacob Thaysen表示:\"Illumina产品和应用的潜在需求仍然强劲,我们在推动利润率和盈利扩张方面正在取得显著进展。\"从积极方面来看,Illumina上调了全年调整后每股收益指引至4.05美元至4.15美元区间,高于3.91美元的共识预期。","market":"us","thumbnail":"https://community-static.tradeup.com/news/af5531973f88f0f2a26021bdeced65c5","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/af5531973f88f0f2a26021bdeced65c5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Illumina第四季度收入指引令人失望","news_tag":"Business Data,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"gpt_icon":1},{"id":"2480802561","title":"因美纳将于美国人类遗传学会(ASHG)年会预展NGS及多组学技术前沿创新成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2480802561","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480802561?lang=zh_cn&edition=full","pubTime":"2024-11-01 12:56","pubTimestamp":1730436960,"startTime":"0","endTime":"0","summary":"将蛋白质组学纳入因美纳的新一代测序产品组合,能够让整个生物过程清晰可见。预计到2025年初推出时,Illumina Protein Prep将涵盖9,000种独特的人类蛋白质。关于因美纳 因美纳公司致力于推动和激发基因组学的发展而不断改善人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4546286_ZH46286_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4588","ILMN","BK4121","BK4548","BK4179","BK4534","NGS","BK4535","BK4585"],"gpt_icon":0},{"id":"2479722217","title":"美国研究综述-全州保险公司、布林克国际公司、梅塔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479722217?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:30","pubTimestamp":1730359839,"startTime":"0","endTime":"0","summary":" 路透10月31日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Allstate、Brinker International 和 Meta。要闻 * 全州公司 :摩根大通将目标价从207美元上调至217美元 * Blackbaud Inc :贝雅将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Meta :贝尔德将目标价从605美元上调至630美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRC","BRO","ITCI","LU2125910336.SGD","NVDA","SOFI","JKHY","AFRM","HLI","ABBV","CDW","COIN","DASH","EAT","IRTC","LU0354030438.USD","SKY","CRK","HUBG","BK4130","ALKT","LU0106261372.USD","ATI","CAT","CRWD","BLKB","EQT","RIOT","LU0882574055.USD","LU1064131342.USD","LU0708994859.HKD","BIDU","BABA","ALRS","BKNG","IE00BYQQ9H92.USD","GEHC","BIIB","EBAY","LU2023250504.SGD","ALL","FSBC","DHI","RIVN","IE00B19Z4B17.USD","CTSH","HTLF","MSTR","ECL","BIO","KHC","ILMN","GRAB","CLX","PDD","CFLT","FND","LU1059921491.USD","IE00B19Z6F94.USD","ADP"],"gpt_icon":1},{"id":"2477913063","title":"Corvex 创始人迈斯特认为已被其他公司盯上的股票有很大的上升空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2477913063","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477913063?lang=zh_cn&edition=full","pubTime":"2024-10-23 05:28","pubTimestamp":1729632491,"startTime":"0","endTime":"0","summary":"Corvex Management公司创始人 迈斯特说: \"他们已经做了工作,我们认为他们是可信的,\"他指的是他的前老板卡尔-伊坎、经营Mantle Ridge的保罗-希拉尔和经营Starboard Value的杰夫-史密斯。他在周二于纽约举行的 13D Monitor 主动-被动投资者峰会上说,追随其他激进分子进入一只股票可能是一种富有成效的策略。迈斯特说,这些公司做了大量研究,并提出了合理的建议,从而启动了变革。迈斯特认为,Illumina 的股价在过去 52 周内已经上涨了 24%,还有 50%的上涨空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4585","LU0006061336.USD","BK4155","ILMN","BK4114","BK4548","FTRE","DLTR","BK4588","BK4534","BK4535","BK4121"],"gpt_icon":0},{"id":"2476166348","title":"美国研究综述-星座能源、摩根士丹利、优步","url":"https://stock-news.laohu8.com/highlight/detail?id=2476166348","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476166348?lang=zh_cn&edition=full","pubTime":"2024-10-17 14:12","pubTimestamp":1729145567,"startTime":"0","endTime":"0","summary":" 路透10月17日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括星座能源、摩根士丹利和优步。要闻 * 星座能源公司 :摩根大通给予其 \"增持 \"评级 * Illumina Inc :汇丰银行将其评级从 \"持有 \"上调至 \"买入 * 摩根士丹利 :加拿大皇家银行将目标价从 108 美元上调至 122 美元 * Uber :大和资本市场将其评级从 \"跑赢大盘 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d624655ffc84aed2346856e3459957e7","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","LU1989772840.SGD","CFG","LU1363072403.SGD","PNFP","OKTA","CSGP","ENPH","VRSK","SYF","LU2237957811.SGD","ULTA","IE00B66KJ199.SGD","LU0225283273.USD","BK4148","FLS","LU0278409577.USD","ABT","LU0823414551.USD","CCI","UAL","NEM","LII","FTV","MS","TRTX","USB","CURB","GNRC","GWW","DOV","CARR","PPG","LU0320765059.SGD","LU2468319806.SGD","CEG","MMM","BK4123","WCC","FANG","S","UBER","BK4082","CSX","FHN","TLN","LFUS","ILMN","MC"],"gpt_icon":1},{"id":"2475037968","title":"BUZZ-伯恩斯坦预计美国生命科学企业第三季度业绩 \"不可怕","url":"https://stock-news.laohu8.com/highlight/detail?id=2475037968","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475037968?lang=zh_cn&edition=full","pubTime":"2024-10-16 18:50","pubTimestamp":1729075822,"startTime":"0","endTime":"0","summary":" 10月16日 - ** 经纪公司伯恩斯坦预计,美国生命科学和工具公司的第三季度财报季 \"并不可怕\",这对投资者来说 \"将是真正的享受\"。** 伯恩斯坦称,安捷伦 和沃特斯 是第三季度的医疗仪器重磅公司,中国市场的销售和需求出现复苏迹象。** 经纪公司预计赛默飞 、Revvity 和Avantor 的第三季度业绩 \"好坏参半\"。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","A","LU1057294990.SGD","LU1721428933.USD","LU1988902786.USD","ILMN","LU0528227936.USD","IE00B1BXHZ80.USD","RVTY","LU1023059063.AUD","IE00B19Z9505.USD","BK4534","IE00BKPKM429.USD","LU0266013472.USD","IE00BJJMRZ35.SGD","BK4533","LU2413666426.HKD","BK4567","LU0061474960.USD","LU0122379950.USD","LU0234572021.USD","LU1815333072.USD","LU1923621640.USD","LU1548497426.USD","BK4548","BK4566","LU2041044095.USD","WAT","BK4535","LU2089984988.USD","LU1543694498.USD","LU1983299246.USD","AVTR","LU1633808545.USD","LU2413666699.HKD","BK4585","LU2092937221.SGD","LU1923622291.USD","GB00BDT5M118.USD","LU0316494557.USD","IE0002141913.USD","LU0347712357.USD","LU1291159041.SGD","TMO","BK4121","LU1165135440.EUR","IE00BJT1NW94.SGD","LU1280957306.USD","PACB","LU0882574055.USD"],"gpt_icon":0},{"id":"2474739500","title":"因美纳推出迄今为止产品系列中最简便、最快速的桌面式测序仪----MiSeq i100系列","url":"https://stock-news.laohu8.com/highlight/detail?id=2474739500","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474739500?lang=zh_cn&edition=full","pubTime":"2024-10-10 09:24","pubTimestamp":1728523440,"startTime":"0","endTime":"0","summary":"全新推出的MiSeq i100响应于这些诉求,集成了上述优势。\" MiSeq i100系列的研发基于因美纳2011年推出的MiSeq桌面式测序仪,自发布起,因美纳客户曾通过MiSeq测序仪推动了大量基因组学发现。MiSeq i100经全新设计,融合了NovaSeq X系列的突破性创新和化学技术,将助力推动下一个基因组学发展和发现时代的到来。\" 首批客户反馈 因美纳与全球范围内的客户开展了MiSeq i100的早期试用。MiSeq i100系列将于2025年面向全球发货。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4527904_ZH27904_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4179","BK4534","BK4585","BK4548","BK4121","ILMN","BK4588","BK4535","NGS"],"gpt_icon":0},{"id":"2474273982","title":"Illumina 推出结构紧凑、成本低廉的基因测序设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2474273982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474273982?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:03","pubTimestamp":1728489785,"startTime":"0","endTime":"0","summary":"新一代测序仪,如Illumina的MiSeq设备,有助于确定DNA或RNA的序列,研究与疾病相关的基因变异,诊断罕见的遗传病。与Illumina的NovaSeq X设备不同,新型MiSeq i100和MiSeq i100 Plus系统体积小巧,可放置在工作台上,使通常外包基因测序的小型实验室也能在内部进行测序。Illumina公司表示,这些设备中使用的试剂可在室温下运输和储存,无需昂贵而笨重的冷冻箱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BK4535","BK4534","BK4548","BK4585","BK4121","BK4588"],"gpt_icon":0},{"id":"1116331317","title":"异动解读 | 伊鲁米纳公司股价暴涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116331317","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116331317?lang=zh_cn&edition=full","pubTime":"2024-10-02 23:42","pubTimestamp":1727883749,"startTime":"0","endTime":"0","summary":"北京时间2024年10月2日,生命科学公司伊鲁米纳股价在当日盘中大涨5.82%,报收于135.60美元,引发市场广泛关注。尽管并无直接消息指明伊鲁米纳股价今日暴涨的原因,但分析人士普遍认为,公司优异的财务数据和有利的行业环境或许是导致股价走高的主要推手。同时,生命科学行业当日整体上涨0.5%,公司股价自三个月前以来已累计大涨超过20%,反映了市场对伊鲁米纳长期前景的看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"gpt_icon":0},{"id":"2472520575","title":"因美纳盘中异动 股价大涨5.13%报135.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472520575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472520575?lang=zh_cn&edition=full","pubTime":"2024-10-02 23:17","pubTimestamp":1727882260,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日23时17分,因美纳股票出现波动,股价快速上涨5.13%。截至发稿,该股报135.60美元/股,成交量61.9801万股,换手率0.39%,振幅6.39%。因美纳股票所在的生命科学行业中,整体涨幅为0.50%。因美纳的高通量技术使人类和其他大型生物的全基因组测序成为可能。因美纳还销售微阵列,可实现低成本、集中的基因筛查,主要用于消费者和农业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100223174198e3a3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100223174198e3a3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4535","BK4585","BK4121","ILMN","BK4534","BK4548"],"gpt_icon":0},{"id":"2467765877","title":"BUZZ-在加拿大皇家银行将 PT 上调至街市高位后,Illumina 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467765877","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467765877?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:07","pubTimestamp":1726236447,"startTime":"0","endTime":"0","summary":" 9月13日 - ** 基因测序设备制造商Illumina 股价上涨1.8%至128.49美元 ** 经纪公司加拿大皇家银行资本市场将PT值从242美元上调至252美元,股票评级为 \"跑赢大盘\"。** 新的预测值比上次收盘价上涨了99.6%。** 25 家券商中有 13 家将该股评级为 \"买入 \"或更高,11 家为 \"持有\",1 家为 \"卖出\";他们的预测中值为 141 美元** 包括盘中走势在内,该股今年累计下跌 5.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BK4588","BK4548","BK4534","PT","BK4121","BK4535","BK4166","BK4585"],"gpt_icon":0},{"id":"2464277008","title":"监管里程碑事件!法院判定欧盟委员会在Illumina(ILMN.US)-Grail(GRAL.US)收购案中越权","url":"https://stock-news.laohu8.com/highlight/detail?id=2464277008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464277008?lang=zh_cn&edition=full","pubTime":"2024-09-03 17:25","pubTimestamp":1725355517,"startTime":"0","endTime":"0","summary":"智通财经获悉,根据欧盟最高法院的一项裁决,基因测序公司Illumina放弃以70亿美元收购癌症检测供应商Grail的交易本不应受到欧盟的调查。欧盟委员会此前对Illumina以70亿美元收购Grail的罚款裁决,标志着欧盟委员会首次使用新的权力来监管对收入很少或没有收入的初创企业的收购,这些初创企业此前逃过了反垄断监管。在周二的裁决之后,Illumina针对欧盟委员会裁决提出的其他几项上诉现在可能会被驳回。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GRAL","ILMN","BK4588","BK4548","BK4534","BK4121","BK4535","BK4585","BK4139"],"gpt_icon":0},{"id":"2464217528","title":"更新版 1-Illumina赢得 \"圣杯 \"之战,打击欧盟兼并势力","url":"https://stock-news.laohu8.com/highlight/detail?id=2464217528","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464217528?lang=zh_cn&edition=full","pubTime":"2024-09-03 16:41","pubTimestamp":1725352890,"startTime":"0","endTime":"0","summary":"不过,这对Illumina公司的影响可能有限,该公司在6月份再次分拆了Grail公司,以遵守欧盟的命令,保留了14.5%的少数股权。2022 年,在 Illumina 对欧盟的兼并审查提出质疑后,欧盟普通法院裁定欧盟执委会胜诉。Illumina表示,欧盟法院的裁决意味着它不必支付罚款。\"今天的判决证实了Illumina长期以来的观点,即欧盟执委会对这一并购案的管辖权是越权的。这些案件是 C-611/22 P Illumina 诉欧盟执委会案和 C-625/22 P Grail 诉欧盟执委会案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ILMN","GRAL","BK4139","BK4534","BK4548","BK4535","BK4121","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.illumina.com","stockEarnings":[{"period":"1week","weight":-0.1062},{"period":"1month","weight":-0.0614},{"period":"3month","weight":0.0364},{"period":"6month","weight":0.2159},{"period":"1year","weight":0.4186},{"period":"ytd","weight":-0.0301}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成,2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务,包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.708333,"avgChangeRate":0.095946},{"month":2,"riseRate":0.375,"avgChangeRate":-0.031971},{"month":3,"riseRate":0.583333,"avgChangeRate":0.006724},{"month":4,"riseRate":0.625,"avgChangeRate":0.018732},{"month":5,"riseRate":0.541667,"avgChangeRate":0.038008},{"month":6,"riseRate":0.708333,"avgChangeRate":0.032137},{"month":7,"riseRate":0.708333,"avgChangeRate":0.019105},{"month":8,"riseRate":0.44,"avgChangeRate":-0.004142},{"month":9,"riseRate":0.48,"avgChangeRate":0.000211},{"month":10,"riseRate":0.56,"avgChangeRate":0.018615},{"month":11,"riseRate":0.52,"avgChangeRate":0.006528},{"month":12,"riseRate":0.666667,"avgChangeRate":0.03466}],"exchange":"NASDAQ","name":"Illumina","nameEN":"Illumina"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Illumina,ILMN,Illumina股票,Illumina股票老虎,Illumina股票老虎国际,Illumina行情,Illumina股票行情,Illumina股价,Illumina股市,Illumina股票价格,Illumina股票交易,Illumina股票购买,Illumina股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}